標(biāo)題: Titlebook: Cardiac Arrhythmias, Pacing and Sudden Death; Peter Kowey,Jonathan P. Piccini,James A. Reiffel Book 2017 Springer International Publishing [打印本頁] 作者: Localized 時(shí)間: 2025-3-21 19:54
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death影響因子(影響力)
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death影響因子(影響力)學(xué)科排名
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death網(wǎng)絡(luò)公開度
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death被引頻次
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death被引頻次學(xué)科排名
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death年度引用
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death年度引用學(xué)科排名
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death讀者反饋
書目名稱Cardiac Arrhythmias, Pacing and Sudden Death讀者反饋學(xué)科排名
作者: 全能 時(shí)間: 2025-3-21 22:11
Pathophysiology of Atrial Fibrillation,cardiovascular abnormalities, including heart failure (HF), hypertension, valvular and ischemic heart disease. These derangements cause or promote the development of AF triggers and atrial remodeling giving rise to the arrhythmogenic substrate. Rapid activation of the atria during AF leads to furthe作者: subordinate 時(shí)間: 2025-3-22 02:56 作者: fledged 時(shí)間: 2025-3-22 06:13 作者: Demulcent 時(shí)間: 2025-3-22 08:45 作者: 過于平凡 時(shí)間: 2025-3-22 16:31 作者: 過于平凡 時(shí)間: 2025-3-22 17:25 作者: miracle 時(shí)間: 2025-3-22 23:19 作者: 賭博 時(shí)間: 2025-3-23 04:30
Anticoagulants for Atrial Fibrillation,temic thromboembolism and mortality in AF patients at a high risk. Traditionally, the vitamin K antagonists (VKAs) were the only anticoagulants, but more recently, the non-vitamin K antagonist oral anticoagulants (NOACs) have become available as alternatives to VKAs. Each NOAC has its own features, 作者: Medicare 時(shí)間: 2025-3-23 07:11 作者: 輕浮女 時(shí)間: 2025-3-23 13:44
Implantable and Wearable Defibrillator Therapy,primary and secondary prevention of sudden cardiac death. When used in conjunction with cardiac resynchronization therapy for patients with impaired left ventricular function, left bundle-branch block, and heart failure, ICDs have resulted in decreased heart failure hospitalizations and prolonged su作者: 違抗 時(shí)間: 2025-3-23 16:48 作者: 事情 時(shí)間: 2025-3-23 19:27 作者: 鋼盔 時(shí)間: 2025-3-24 02:11 作者: 緯度 時(shí)間: 2025-3-24 05:34
Clinical Management of Atrial Fibrillation,etermination of AF type (paroxysmal or persistent), burden, symptoms, and risk for thromboembolism and stroke. Treatment strategies can then be selected focusing on rate vs. rhythm control and stroke risk reduction. Rate control is typically achieved with medical therapy, but AV junctional ablation 作者: 英寸 時(shí)間: 2025-3-24 10:22 作者: 高貴領(lǐng)導(dǎo) 時(shí)間: 2025-3-24 11:57 作者: HOWL 時(shí)間: 2025-3-24 14:50
Bradyarrhythmias/Heart Blocks,he cardiac electrophysiological system are reviewed to provide a framework for an understanding of the patterns of sinus node, AV node, and His-Purkinje system dysfunction that result in clinical bradyarrhythmias. The important pathologic processes leading to these clinical bradyarrhythmias are disc作者: deciduous 時(shí)間: 2025-3-24 19:05
Syncope and Risk of Sudden Death, are presumed to have had syncope. However, before a clinician can attempt to assess mortality risk relative to an episode of syncope, it is first essential to determine that collapse was in fact due to syncope (i.e., transient self-limited loss of consciousness due to cerebral hypoperfusion) and no作者: jovial 時(shí)間: 2025-3-24 23:46
Atrial Fibrillation Ablation,arrhythmic medications and in selected patients with symptomatic, paroxysmal AF . to a trial of medical therapy, provided that it can be performed at an experienced center. In this chapter, we summarize the state of the art of catheter ablation and how it may utilized to its maximum advantage in patients with this common arrhythmia.作者: hemorrhage 時(shí)間: 2025-3-25 04:19 作者: 效果 時(shí)間: 2025-3-25 10:46 作者: 貧困 時(shí)間: 2025-3-25 15:03 作者: frenzy 時(shí)間: 2025-3-25 18:42 作者: 脫落 時(shí)間: 2025-3-25 20:18 作者: reflection 時(shí)間: 2025-3-26 02:53
Operator Theory: Advances and Applications 24–72 h. Over the past 20 years, a variety of more advanced non-invasive and invasive devices for prolonged rhythm monitoring have entered clinical practice, and the spectrum of clinical indications for their use has progressively expanded.作者: textile 時(shí)間: 2025-3-26 06:18 作者: 口味 時(shí)間: 2025-3-26 09:56
Jean Dolbeault,Maria J. Estebanythm makes CA an option even when multiple and unstable ventricular tachycardias (VTs) are present. Its major role is in controlling of incessant VT and recurrent symptomatic VT in patients with implanted defibrillators. Continued advances in mapping and ablation methods are anticipated to continue to improve efficacy and safety.作者: Negligible 時(shí)間: 2025-3-26 15:59
Mi-Ho Giga,Yoshikazu Giga,Jürgen Saals dependent on perinodal structures, and is independent of atrium and ventricle. AVRT requires both the atrium and ventricle for its maintenance. This chapter will discuss the clinical syndrome, typical scenarios of presentation, and then each type in more detail.作者: Lipoma 時(shí)間: 2025-3-26 18:41 作者: commune 時(shí)間: 2025-3-26 21:57
Genomics of Cardiac Arrhythmias,l fibrillation (AF) and sudden cardiac death (SCD). Further, inexpensive and accurate genotyping and sequencing technologies introduced in the last decade are revolutionizing not only diagnostics and patient care, but are also introducing new complexities in interpretation of genetic test data with which physicians are only now becoming aware.作者: 慢跑鞋 時(shí)間: 2025-3-27 03:54
Extended ECG Monitoring, 24–72 h. Over the past 20 years, a variety of more advanced non-invasive and invasive devices for prolonged rhythm monitoring have entered clinical practice, and the spectrum of clinical indications for their use has progressively expanded.作者: Feedback 時(shí)間: 2025-3-27 05:55 作者: 保守黨 時(shí)間: 2025-3-27 13:20
Ventricular Tachycardia Ablation,ythm makes CA an option even when multiple and unstable ventricular tachycardias (VTs) are present. Its major role is in controlling of incessant VT and recurrent symptomatic VT in patients with implanted defibrillators. Continued advances in mapping and ablation methods are anticipated to continue to improve efficacy and safety.作者: 裹住 時(shí)間: 2025-3-27 15:28
Supraventricular Tachycardia,s dependent on perinodal structures, and is independent of atrium and ventricle. AVRT requires both the atrium and ventricle for its maintenance. This chapter will discuss the clinical syndrome, typical scenarios of presentation, and then each type in more detail.作者: 疏忽 時(shí)間: 2025-3-27 18:30 作者: labyrinth 時(shí)間: 2025-3-28 00:11
Book 2017ery, interventions, treatment and preventive cardiology. This coverage is presented? with consistent chapter organization, clear design, and engaging text that includes user-friendly features such as tables, lists and treatment boxes..作者: 溫順 時(shí)間: 2025-3-28 04:22 作者: Yag-Capsulotomy 時(shí)間: 2025-3-28 10:10
https://doi.org/10.1007/978-3-7643-8814-0avior. Thus, health care providers should have a basic understanding of the pacemaker components, pacing nomenclature, pacing modes, indication, follow up and electrocardiographic features of pacemakers. Device malfunction can be recognized with subsequent proper troubleshooting if one understands normal pacemaker behavior.作者: 灰姑娘 時(shí)間: 2025-3-28 13:49 作者: Macronutrients 時(shí)間: 2025-3-28 16:52 作者: 虛弱 時(shí)間: 2025-3-28 19:09 作者: obsession 時(shí)間: 2025-3-29 02:06 作者: 無聊點(diǎn)好 時(shí)間: 2025-3-29 03:39
Implantable and Wearable Defibrillator Therapy, the wearable cardiac defibrillator in prevention of sudden cardiac death in high-risk populations remains less clearly defined due to the absence of appropriate designed prospective randomized trials.作者: BRAWL 時(shí)間: 2025-3-29 07:25
Clinical Management of Atrial Fibrillation, novel oral anticoagulants and mechanical closure of the left atrial appendage now offer alternative approaches. A thorough understanding of the risks and benefits of all of these treatment approaches, as well as of the clinical status and preferences of each patient, is necessary to provide optimal individualized care to patients with AF.作者: caldron 時(shí)間: 2025-3-29 12:30 作者: GUMP 時(shí)間: 2025-3-29 17:26
Pathophysiology of Atrial Fibrillation,ed to be due largely to a reentrant mechanism(s), but direct evidence is often lacking and the controversy continues. The development and maintenance of AF are multifactorial and involve dynamic pathophysiologic processes which are in many cases not well defined or understood. This chapter reviews o作者: bromide 時(shí)間: 2025-3-29 22:48
Channelopathies: Clinical Presentation and Genetics,discussed in this chapter. As will be outlined, not only can genetics help (or complicate) diagnosis of these channelopathies, important genotype-phenotype correlations have emerged that might aid in risk stratification for these conditions, and genotype specific therapies are available in certain s作者: 完成 時(shí)間: 2025-3-30 03:55 作者: Cpap155 時(shí)間: 2025-3-30 07:58
Antiarrhythmic Drug Management of Atrial Fibrillation,tiarrhythmic is usually made on the basis of the underlying cardiovascular status. In patients with heart failure only dofetilide and amiodarone are considered, and in patients with coronary artery disease disopyramide, flecainide and propafenone are avoided. Dronedarone must be avoided if there is 作者: 單挑 時(shí)間: 2025-3-30 10:40 作者: 除草劑 時(shí)間: 2025-3-30 15:02 作者: bibliophile 時(shí)間: 2025-3-30 18:55 作者: 逢迎白雪 時(shí)間: 2025-3-31 00:37
Operator Theory: Advances and Applicationsed to be due largely to a reentrant mechanism(s), but direct evidence is often lacking and the controversy continues. The development and maintenance of AF are multifactorial and involve dynamic pathophysiologic processes which are in many cases not well defined or understood. This chapter reviews o作者: 矛盾 時(shí)間: 2025-3-31 03:44
Operator Theory: Advances and Applicationsdiscussed in this chapter. As will be outlined, not only can genetics help (or complicate) diagnosis of these channelopathies, important genotype-phenotype correlations have emerged that might aid in risk stratification for these conditions, and genotype specific therapies are available in certain s作者: DIKE 時(shí)間: 2025-3-31 05:04
https://doi.org/10.1007/978-3-7643-8814-0 no single predictor has been shown to have sufficient predictive value to be used to guide preventative therapy and reduce mortality. More recent effort has been directed towards combining markers to increase the sensitivity of identifying high risk cohorts.作者: expansive 時(shí)間: 2025-3-31 10:04 作者: 斜 時(shí)間: 2025-3-31 15:38 作者: d-limonene 時(shí)間: 2025-3-31 18:28 作者: generic 時(shí)間: 2025-4-1 01:22 作者: alcohol-abuse 時(shí)間: 2025-4-1 03:23
978-3-319-86300-9Springer International Publishing AG 2017作者: 去掉 時(shí)間: 2025-4-1 07:47
